Deutsche Bank’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Deutsche Bank’s Portfolio ALXA Stock Details ALXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,500	Closed	-$1K	–	5507
2015 Q2	$1K	Hold	1,500	–	–	﹤0.01%	5300
2015 Q1	$3K	Hold	1,500	–	–	﹤0.01%	4968
2014 Q4	$2K	Hold	1,500	–	–	﹤0.01%	6039
2014 Q3	$3K	Buy	+1,500	New	+$5.72K	﹤0.01%	5636
2013 Q4	–	Sell	-1	Closed	–	–	5919
2013 Q3	$0	Buy	+1	New	+$5	﹤0.01%	5888

Other funds holding ALXA

LPA

Lansdowne Partners Austria Vienna, Austria $29M AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CLOS

Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $8.13B AUM 26.03% 1-Year Est. Return

HHMI

Howard Hughes Medical Institute Chevy Chase, Maryland $416M AUM 13.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Deutsche Bank's ALXA Position: Q3 2015 in Review

Deutsche Bank sold out of Alexza Pharmaceuticals Inc (ALXA) in Q3 2015, closing a stake of 1,500 shares — an estimated $1K sold.

Deutsche Bank first reported a position in ALXA in Q3 2013 and held it in 5 quarters. The position peaked at $3K in Q1 2015. 24 funds tracked by Wall St. Rank hold ALXA as of Q3 2015.

Deutsche Bank reported no remaining Alexza Pharmaceuticals Inc position as of Q3 2015 after selling out during the quarter.
Deutsche Bank sold 1,500 Alexza Pharmaceuticals Inc shares in Q3 2015, an estimated $1K.
Deutsche Bank first reported a position in Alexza Pharmaceuticals Inc in Q3 2013 and held it in 5 quarters.
Deutsche Bank's Alexza Pharmaceuticals Inc position peaked at $3K in Q1 2015.
24 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q3 2015.

Based on Deutsche Bank's 13F filing for Q3 2015, filed 17 Nov 2015.